Epstein Secrets

estricted stocks of companies whose unrestricted shares are freely traded and (ii) studies of private transactions prior to initial public offerings el PO"). While both the restricted stock and pre-IPO studies have been used by appraisers to derive adjustments for lack of marketability, we believe tha

ate Indicated enterprise value (minority, marketable basis) divided by: Company indication2 Implied multiple $286,500 (63,000) 223,500 203,764 EV - Enterprise Value (invested capisol less cash): Fwd - Forward Cash and cash equivalents at the Valuation Date welt based on estimates provided by management. and incl

estricted stocks of companies whose unrestricted shares are freely traded and (ii) studies of private transactions prior to initial public offerings el PO"). While both the restricted stock and pre-IPO studies have been used by appraisers to derive adjustments for lack of marketability, we believe tha

ate Indicated enterprise value (minority, marketable basis) divided by: Company indication2 Implied multiple $286,500 (63,000) 223,500 203,764 EV - Enterprise Value (invested capisol less cash): Fwd - Forward Cash and cash equivalents at the Valuation Date welt based on estimates provided by management. and incl

estricted stocks of companies whose unrestricted shares are freely traded and (ii) studies of private transactions prior to initial public offerings el PO"). While both the restricted stock and pre-IPO studies have been used by appraisers to derive adjustments for lack of marketability, we believe tha

ate Indicated enterprise value (minority, marketable basis) divided by: Company indication2 Implied multiple $286,500 (63,000) 223,500 203,764 EV - Enterprise Value (invested capisol less cash): Fwd - Forward Cash and cash equivalents at the Valuation Date welt based on estimates provided by management. and incl